Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChristie Regulatory News (CTG)

Share Price Information for Christie (CTG)

Share Price is delayed by 15 minutes
Get Live Data
137.50    0.00 (0.00%)
Bid:
135.00
Ask:
140.00
Spread: 5.00 (3.704%)
Market Cap: £35.24m
CTG Live PriceLast checked at - London Stock Exchange

Intraday Christie Share Chart

Trading Statement

18 Sep 2024 07:00

RNS Number : 5949E
Christie Group PLC
18 September 2024
 

18 September 2024

 

Christie Group plc

("Christie Group" or the "Company")

 

Trading Update

 

The Board of Christie Group plc (CTG.L) continues to expect to report a profitable full year performance. However, continuing volatility means that the Board now anticipates the full year profit to be lower than previously expected.Performance for the six months ended 30th June 2024 ("H1")

 

The Group expects to report a H1 operating loss of £0.6m (2023 H1: £1.4m loss) when issuing its Interim Results. This first half operating loss is principally a result of weak invoicing in its International brokerage operations as previously announced and insufficient growth in its visitor attraction software business. H1 operating losses from its retail stocktaking operation are less than H1 2023.

 Current trading & outlook

 

We have invested to build and retain a team which is required to support and sustain future growth and while this has helped boost transactional pipelines across our brokerage business the completion of those transactions is slower than we anticipated. The volume of business we are working on and continued enquiry levels give us confidence in the future success of the brokerage business. 

 

While some volatility has continued into H2 - the Company has just received confirmation that a significant disposal mandate within our agency and advisory business, which had been expected to successfully conclude during Q3, has been aborted at an advanced stage and the vendor has no current plans to pursue a sale with an alternative buyer - transactional pipelines in both our UK and International agency businesses are, nonetheless, encouraging.We ended H1 with a UK transactional pipeline 24% higher than a year ago, and 16% higher than at the start of 2024. New instruction activity from clients across all our specialist sectors seeking to buy and sell businesses remains robust. UK transactional activity has recovered well following the disappointing volumes achieved during 2023, and we anticipate returning to brokering the sale or purchase of over 1,000 businesses in 2024 (2023: 820) with average fees likely to be higher in the second half than H1 due to the sector mix of business.

 

In our international operations, we have grown transactional pipelines significantly, but experienced weaker than anticipated H1 invoicing. This, together with the continued investment to strengthen our teams on the continent, has served to offset an otherwise robust performances from our UK agency, advisory and finance brokerage operations. H2 invoicing in those international operations is expected to be far more positive than H1 from a range of ongoing mandates.

 

Summary

 

As a result of the above, overall group revenues for the full year are expected to be relatively robust and at a level which is at least 95% of previous expectations. However, the mitigating effect of our incentivised pay schemes will not fully offset this revenue shortfall, resulting in a reduction of our full year operating profit expectations. As such, the Board now anticipates reporting a full year operating profit between £0.5m and £1.0m, with this profit range reflecting the ongoing uncertainty on transaction timings.

 

The Group expects to issue its Interim Results on Monday 30th September 2024. Enquiries:

 

Christie Group plc

Dan Prickett 07885 813101

Chief Executive

 

Simon Hawkins 07767 354366

Chief Financial Officer

Shore Capital

Patrick Castle 020 7408 4090

Nominated Advisor and Broker

 

Notes to Editors:

Christie Group plc, quoted on AIM, is a leading professional business services group with 37 offices across the UK and Europe, catering to its specialist markets in the hospitality, leisure, healthcare, medical, childcare & education and retail sectors.

 

Christie Group operates in two complementary business divisions: Professional & Financial Services (PFS) and Stock & Inventory Systems & Services (SISS). These divisions trade under the brand names: PFS - Christie & Co, Pinders, Christie Finance and Christie Insurance: SISS - Orridge, Venners and Vennersys.

 

Tracing its origins back to 1846, the Group has a long-established reputation for offering valued services to client companies in agency, valuation services, investment, consultancy, project management, multi-functional trading systems and online ticketing services, stock audit and inventory management. The diversity of these services provides a natural balance to the Group's core agency business.

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014.

 

For more information, please go to www.christiegroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKDLFFZKLZBBD
Date   Source Headline
17th Jun 20267:01 amRNSHolding(s) in Company
17th Jun 20267:01 amRNSHolding(s) in Company
17th Jun 20267:00 amRNSResult of AGM
16th Jun 20267:00 amRNSAGM Trading Update
22nd May 20269:00 amRNS2025 Annual Report and AGM Notice
30th Apr 20263:36 pmRNSPDMR Notification
27th Apr 20267:00 amRNSPreliminary Results
17th Apr 20267:00 amRNSNotice of Results and Investor Presentation
2nd Apr 20267:00 amRNSClosure of final salary pension schemes
6th Mar 20263:43 pmRNSPDMR Notification
6th Feb 20261:20 pmRNSDirector / PDMR Shareholding
19th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSCompletion of Vennersys sale
23rd Dec 20257:00 amRNSTrading Update
23rd Dec 20257:00 amRNSTrading Update
22nd Dec 20257:00 amRNSSale of Vennersys
22nd Dec 20257:00 amRNSSale of Vennersys
8th Oct 202512:14 pmRNSResilient Market Conditions in Key Sectors
29th Sep 20257:00 amRNSInterim Results
23rd Jul 20257:00 amRNSMid Year Reviews
1st Jul 202512:32 pmRNSChristie & Co advises on sale of Vienna Marriot
12th Jun 20253:04 pmRNSResult of AGM
12th Jun 20257:00 amRNSAGM Trading Update
20th May 20259:38 amRNSHolding(s) in Company
16th May 20259:00 amRNS2024 Annual Report and AGM Notice
8th May 202510:42 amRNSChristie & Co celebrates 90th anniversary
28th Apr 20257:00 amRNSPreliminary Results
21st Jan 20257:00 amRNSFull Year Trading Update
10th Jan 202512:26 pmRNSHolding(s) in Company
6th Nov 20244:33 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSDisposal of Orridge Holdings Limited
30th Sep 20247:00 amRNSInterim Results
26th Sep 20247:00 amRNSDirectorate Change
18th Sep 20247:00 amRNSTrading Statement
13th Jun 202412:06 pmRNSResult of AGM
13th Jun 20247:00 amRNSAGM Trading Update
5th Jun 20249:46 amRNSHolding(s) in Company
17th May 20249:00 amRNS2023 Annual Report and AGM Notice
30th Apr 20242:19 pmRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSDate of Preliminary Statement of Results
15th Feb 20247:00 amRNSTrading Statement
5th Feb 20249:00 amRNSChristie & Co facilitates charitable trust merger
22nd Jan 20247:00 amRNSChristie & Co broker sale of London day nursery
8th Dec 20237:00 amRNSTrading Statement
30th Nov 20237:00 amRNSChristie & Co Care wins at the LaingBuisson Awards
30th Nov 20237:00 amRNSChristie & Co 'team of the year' at dental awards
27th Oct 20237:00 amRNSChristie & Co instructed to market caravan parks
18th Oct 20237:00 amRNSChristie & Co publish key market insights
13th Oct 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.